Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : BXRX save search
Baudax Bio Announces Corporate Update
Published: 2023-10-18 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 25.86%
H: 1.16%
C: -18.31%
update
Baudax Bio Announces Orphan Drug Designation Granted by U.S. FDA for TI-168 for the Treatment of Hemophilia A with Inhibitors
Published: 2023-09-28 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 87.57%
H: 38.62%
C: -19.67%
ti-168 fda drug granted treatment designation
Baudax Bio to Participate in the H.C. Wainwright Global Investment Conference
Published: 2023-09-07 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 1.04%
H: 2.56%
C: 1.28%
conference global
Baudax Bio Announces Distribution of Series C Preferred Stock to Holders of its Common Stock
Published: 2023-08-23 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 6.03%
H: 0.0%
C: -4.53%
distribution
Baudax Bio Announces $1.9 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
Published: 2023-08-17 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: -6.11%
H: 5.53%
C: 0.4%
nasdaq direct offering
Baudax Bio Reports Second Quarter 2023 Financial Results and Provides Business Update
Published: 2023-08-16 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: -3.48%
H: 0.0%
C: 0.0%
business update financial results
Baudax Bio Acquires TeraImmune, Inc.
Published: 2023-06-30 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 23.03%
H: 123.42%
C: 82.81%
Baudax Bio Announces Additional, Positive Top-Line Results From Phase 2 Randomized Clinical Trial of BX1000
Published: 2023-06-07 (Crawled : 13:20) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 7.16%
H: 5.23%
C: -2.57%
bx1000 positive trial results phase 2
Baudax Bio Announces Date of Reconvened Annual Meeting
Published: 2023-06-06 (Crawled : 13:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 1.85%
H: 2.91%
C: 1.8%
meeting
Baudax Bio Reports First Quarter Financial Results and Provides Business Update
Published: 2023-05-12 (Crawled : 12:20) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 2.94%
H: 1.2%
C: -3.14%
business update financial results
Baudax Bio to Present at the Sidoti Virtual Investor Conference
Published: 2023-05-03 (Crawled : 20:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 4.61%
H: 0.0%
C: -1.85%
conference
Baudax Bio Announces Closing of $4 Million Public Offering
Published: 2023-05-01 (Crawled : 22:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 0.31%
H: 1.62%
C: -4.87%
offering
Baudax Bio Announces Pricing of $4 Million Public Offering
Published: 2023-04-27 (Crawled : 02:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: -52.0%
H: 7.11%
C: -7.9%
offering
European Midday Briefing: Mood Darkens as Worries -3- – Morningstar
Published: 2023-04-26 (Crawled : 11:00) - spacfeed.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: -17.22%
H: 6.94%
C: 2.31%
Melrose Education targets SEN school acquisitions – Business Sale Report
Published: 2023-04-26 (Crawled : 11:00) - spacfeed.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: -17.22%
H: 6.94%
C: 2.31%
report acquisitions business education
Self-driving trucks struggle to deliver – Axios
Published: 2023-04-26 (Crawled : 11:00) - spacfeed.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: -17.22%
H: 6.94%
C: 2.31%
trucks
CGI reports strong second quarter Fiscal 2023 results – PR Newswire
Published: 2023-04-26 (Crawled : 11:00) - spacfeed.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: -17.22%
H: 6.94%
C: 2.31%
results
Trump Is Likely To Face Another Indictment For Interfering in the 2020 Elections as His SPAC Digital World Receives a Non-Compliance Letter From Nasdaq – Wccftech
Published: 2023-04-26 (Crawled : 11:00) - spacfeed.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: -17.22%
H: 6.94%
C: 2.31%
nasdaq spac
Baudax Bio Announces Positive Top-Line Final Results From Phase 2 Randomized Clinical Trial of BX1000
Published: 2023-04-25 (Crawled : 13:20) - biospace.com/
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 63.83%
H: 12.66%
C: -32.14%
bx1000 positive trial results phase 2
Baudax Bio to Host Key Opinion Leader Webinar to Discuss Results of Phase 2 BX1000 Trial
Published: 2023-04-24 (Crawled : 21:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 63.83%
H: 12.66%
C: -32.14%
bx1000 trial results phase 2
Gainers vs Losers
| 69% | 31% |
Top 10 Gainers
SLDB | News M | $5.89 72.22% 41.94% 12M
|
Health Technology
SVFD | News | $3.09 43.72% 30.42% 64M
|
FTEL | $2.04 43.66% 30.39% 110K
|
HPCO 4 | $0.4824 41.92% 29.54% 28M
|
ALGS | News | $0.6475 -5.06% 26.67% 2.1M
|
Health Technology
GTHX | $3.16 30.58% 23.42% 10M
|
Health Technology
KEQU | $22.5 27.62% 21.64% 24K
|
Producer Manufacturing
GSIT | $3.09 27.16% 21.36% 2.2M
|
Electronic Technology
SSKN P | $0.628 25.6% 20.38% 210K
|
Health Technology
GLUE | $3.66 22.82% 18.58% 510K
|
Professional, Scientific, and T...
Your saved searches
Save your searches and get alerts when important news are released.